0 antall prosjekter

KREFT-Offentlig kreftprogram

Molecular and biological characterization of cancer metastases

Purpose: Metastasis is the principal cause of cancer death, and for most tumor types staging, prognostication and therapy is inadequate. Hence, new knowledge on how to prevent metastasis and identification of predictive markers is among the most important challenges in cancer research. Our strat...

Tildelt: kr 6,7 mill.

Prosjektperiode: 2009-2013

Sted: Oslo

GNBIO-Grunnleggende næringsrettet bioteknologi

Tumor Targeting Antibodies in Colorectal Cancer

Objective: The main purpose is to identify and characterize novel antibodies recognizing specific antigens on colorectal cancer cells. Interesting candidates will be thoroughly examined for their specificity and their ability to be used as diagnostic and/ or prognostic markers. Their potential as...

Tildelt: kr 2,2 mill.

Prosjektperiode: 2007-2011

Sted: Oslo

INT-BILAT-BILAT-ordningen

USA - Strengthening Collaborative Research on Cancer Metastasis between Cancer Institutions in Norway and USA

The three partcipating institutions have already ongoing collaborations in the metastasis field in tumor types such as malignant melanoma and sarcoma. To strengthen the scientific and administrative basis for these projects, and to review and explore the opportunities for making the results of th...

Tildelt: kr 0,15 mill.

Prosjektperiode: 2006-2007

Sted: Oslo

KREFTSATS-Særutlysning kreftmidler, historikk

MOLECULAR AND BIOLOGICAL STUDIES OF CANCER METASTASIS

Metastasis, cancer spread to other organs, is the principle cause of death of cancer patients. Early detection of metastatic tumor cells, development of new treatment strategies and knowledge about how to prevent cancer metastasis are some of the most cha llenging tasks in cancer research. Our pr...

Tildelt: kr 6,0 mill.

Prosjektperiode: 2005-2009

Sted: Oslo

GNBIO-Grunnleggende næringsrettet bioteknologi

Selection and characterization of novel cancer specific antibodies – utilization in diagnostic and therapeutic approaches

Objective: The main purpose is to identify and characterize novel breast cancer specific antibodies. Interesting candidates will be thoroughly characterized for their specificity. Fulfilling the specificity criteria their potential as diagnostic or progno stic markers will be investigated. Finall...

Tildelt: kr 4,0 mill.

Prosjektperiode: 2005-2010

Sted: Ukjent Fylke

FRIMED-Klinisk medisin og folkehelse

Studies of colorectal cancer (CRC) metastasis

...

Tildelt: kr 1,0 mill.

Prosjektperiode: 2004-2007

Sted: Oslo

KREFTSATS-Særutlysning kreftmidler, historikk

Biological, diagnostic and therapeutic aspects of cancer metastasis

...

Tildelt: kr 8,8 mill.

Prosjektperiode: 2001-2005

Sted: Oslo